Facility Evaluation Report

Licensing Program Analyst (LPA) Huma Rahimi conducted unannounced visit to this facility in conjunction with a complaint control # 31-AS-20250131102508. LPA met with the Administrator Kristina Admayan who granted access to facility. LPA explained the reason for the visit.

During the visit LPA requested to review the medication for Resident #2 (R2) who seemed drowsy. Review of medication revealed that a bubble pack of thirty (30) tablets of Januvia 25MG (Type 2 Diabetes) which was filled on 12/30/2024 was supposed to be given to R2 one tablet daily. However, LPA observed that there are eight (8) extra tablets in the bubble pack. Additionally, LPA observed a full bubble pack of the same medication which was filled on 01/27/2025. LPA asked the Administrator and the staff for explaining and both stated that R2 refuses taking medication. LPA was informed that R2's POA advised the Administrator not to provide medication if R2 refuses. Administrator informed LPA that they did not inform R2's Physician nor submitted an incident report to Community Care Licensing Department (CCLD).

Appeal rights given. Exit interview conducted.